Zosano Pharma
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Show More
CEO
Mr. Steven Lo
Employees
45
Country
Germany
ISIN
US98979H1032
Listings
0 Comments
Share your thoughts
FAQs
What is Zosano Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Zosano Pharma stocks are traded under the ticker 0ZP.STU.
How many employees does Zosano Pharma have?▼
As of November 1, 2026, the company has 45 employees.
In which sector is Zosano Pharma located?▼
Zosano Pharma operates in the Health & Wellness sector.
When did Zosano Pharma complete a stock split?▼
The last stock split for Zosano Pharma was on January 29, 2018 with a ratio of 1:20.
Where is Zosano Pharma headquartered?▼
Zosano Pharma is headquartered in Fremont, Germany.